The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...
BioMerieux shares rose after the in vitro diagnostics specialist said it acquired diagnostics technology provider SpinChip Diagnostics for an enterprise value of 138 million euros ($141.5 million).
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid ...